Antidepressant use has been linked to thicker arteries, possibly contributing to the risk of heart disease and stroke, in a...
A new study reports an antidepressant temporarily inhibits the blood-brain barrier, allowing drugs to enter the brain. The findings could have implications for treating neurological diseases from ALS to epilepsy.
Researchers believe the newly understood mechanism could yield insights into more precise future treatments for nerve pain and depression.
Taking SSRI antidepressants does not increase the risk of developmental delays or autism in children, a new study reports. However, there is an increased risk for ASD and developmental delays in children whose mothers suffer from maternal psychiatric disorders.
Fetal exposure to SRI antidepressants may affect the brain activity in newborns, a new study reports.
Study reveals a link between people with depression who are prescribed newer antipsychotic medications and higher mortality risk.
Alteration of placental serotonin levels due to maternal depression or antidepressant use may be associated with the disruption of placental estrogen production.
Researchers critique the latest findings on serotonin's role in depression and report people should maintain their current therapies to help control their symptoms of depression.
Neuroscientists found that astrocytes may be responsible for the rapid improvement in mood in depressed patients after acute sleep deprivation. This study identified how astrocytes can regulate a neurotransmitter involved in sleep.
Study reports people who experience bullying or abuse have a lower quality of life comparable to those living with chronic health conditions, such as diabetes or depression. The study also reports those who are abused are more likely to develop harmful behaviors such as smoking or binge eating.
Researchers suggest serotonin metabolism in the pineal gland could play a role in the underlying cause of depression. The findings were based on biochemical changes which were seen to be in association with improvements in depression.
According to researchers, combining tricyclic antidepressants with blood thinners increased tumor autophagy in mouse models of glioblastoma brain cancer.
